Alembic says it received tentative USFDA nod for its anti-cardiac stroke medicine

This drug has an estimated market size of $465 million for twelve months ending December 2021

Related Keywords

Tata Neu ,Dabigatran Etexilate ,Boehringer Ingelheim Pharmaceuticals ,Alembic Pharmaceuticals Limited On ,Us Food Drug Administration ,Alembic Pharmaceuticals Limited ,Drug Administration ,Abbreviated New Drug Application ,Pradaxa Capsules ,Boehringer Ingelheim ,Elevation Capital ,Alembi ,Drugs ,Usfda ,Nti Cardiac ,Us Food Amp Drug Administration ,